Director, State Government Affairs Remote

Remote - USA;
San Francisco, California, United States;
Washington DC

When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on. In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early‑stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way.

We build bridges to groundbreaking advancements in rare disease, and develop life‑changing medicines for patients with unmet needs as fast as humanly possible. Together we define white space, push boundaries and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask “why not?”

and help reengineer the future of biopharma.

Bridge Bio is establishing a dedicated leadership role to build and lead the company’s state government affairs function. As part of the Government Affairs team, the Director, State Government Affairs will develop and drive a comprehensive state engagement strategy, drawing on established networks and building strategic relationships with state policymakers and stakeholders. The Director, State Government Affairs will lead Bridge Bio’s engagement on state health policies, including Medicaid coverage, diagnosis, and access frameworks, positioning the company to anticipate and influence evolving state reimbursement environments.

This leader will monitor, assess, and anticipate evolving state policy landscapes, translating complex policy developments into clear, actionable business implications for executive leadership and cross‑functional partners.

• Develop and drive a proactive, multi‑state strategy across priority states, aligned with enterprise priorities, portfolio objectives, and commercial planning.
• Identify, assess, and influence state legislation, regulations, and executive actions impacting pricing, reimbursement, Medicaid, PBM reform, 340B, newborn screening, rare disease access, and innovation policy.
• Anticipate state political, legislative, and regulatory trends, translating complex developments into clear business risks, opportunities, and recommended actions for executive leadership.
• Lead coordinated advocacy campaigns in priority states, integrating direct lobbying, state trade association engagement, and coalition strategy to shape outcomes before they materially affect the business.
• Maintain disciplined oversight of all state lobbying and political compliance processes, ensuring all activity meets reporting requirements and that advocacy activities adhere to applicable state ethics and disclosure laws.

• Leverage established relationships and strategically build Bridge Bio’s engagement with governors’ offices, state legislators and regulators, Medicaid and insurance leaders, and key staff to advance the company’s state policy priorities.

Represent Bridge Bio in state coalitions, and industry forums, serving as a credible and persuasive voice for the company’s positions.

• Lead engagement within state trade associations and coalitions, consultants, driving aligned action on priority issues while protecting Bridge Bio’s independent strategy.

This role is responsible for executing and advancing Bridge Bio’s enterprise policy positions at the state level, in close coordination with the Head of Public Policy and Federal Government Affairs.

Partner with key internal stakeholders including Commercial, Market Access and Patient Advocacy to integrate state policy strategy into coverage, reimbursement, and patient access planning, ensuring advocacy efforts directly support portfolio objectives and patient access across priority states.

• Advise executive leadership and cross‑functional teams on state‑level legislative and regulatory developments, translating state political dynamics into clear implications for pricing, reimbursement, Medicaid coverage, and patient access…